Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) FCF Margin (2020 - 2025)

BioAtla (BCAB) has disclosed FCF Margin for 4 consecutive years, with 395.75% as the latest value for Q4 2025.

  • For Q4 2025, FCF Margin changed N/A year-over-year to 395.75%; the TTM value through Dec 2025 reached 2410.2%, down 175624.0%, while the annual FY2025 figure was 2410.2%, 175624.0% down from the prior year.
  • FCF Margin hit 395.75% in Q4 2025 for BioAtla, down from 46.65% in the prior quarter.
  • Across five years, FCF Margin topped out at 46.65% in Q3 2024 and bottomed at 5682.8% in Q2 2021.
  • Average FCF Margin over 3 years is 2041.73%, with a median of 395.75% recorded in 2025.
  • On a YoY basis, FCF Margin climbed as much as -411280bps in 2021 and fell as far as -411280bps in 2021.
  • BioAtla's FCF Margin stood at 5682.8% in 2021, then soared by 99bps to 46.65% in 2024, then tumbled by -748bps to 395.75% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 395.75%, 46.65%, and 5682.8% for Q4 2025, Q3 2024, and Q2 2021 respectively.